X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (67968) 67968
Book Review (9611) 9611
Publication (4273) 4273
Newsletter (945) 945
Book Chapter (256) 256
Book / eBook (190) 190
Conference Proceeding (188) 188
Magazine Article (40) 40
Dissertation (32) 32
Government Document (23) 23
Web Resource (12) 12
Newspaper Article (7) 7
Data Set (5) 5
Streaming Video (3) 3
Paper (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (64410) 64410
humans (56593) 56593
animals (27677) 27677
female (26781) 26781
male (18669) 18669
mice (18284) 18284
oncology (17138) 17138
middle aged (13541) 13541
cancer (12201) 12201
adult (11709) 11709
aged (10688) 10688
antibodies (9913) 9913
immunology (8767) 8767
antibodies, monoclonal - immunology (8505) 8505
immunotherapy (7483) 7483
antibodies, monoclonal - therapeutic use (7350) 7350
abridged index medicus (6789) 6789
expression (6743) 6743
immunohistochemistry (6699) 6699
neoplasms - immunology (6694) 6694
antibodies, monoclonal (6639) 6639
tumors (6253) 6253
antigens, neoplasm - immunology (6150) 6150
cell line, tumor (6136) 6136
fluorescent antibody technique (5296) 5296
tumor cells, cultured (5279) 5279
monoclonal antibodies (5187) 5187
research (4936) 4936
cell line (4620) 4620
mice, inbred balb c (4586) 4586
neoplasm transplantation (4295) 4295
antigens (4213) 4213
monoclonal-antibody (3974) 3974
pathology (3903) 3903
proteins (3892) 3892
antigens, neoplasm - analysis (3883) 3883
prognosis (3874) 3874
t-lymphocytes - immunology (3772) 3772
care and treatment (3649) 3649
carcinoma (3536) 3536
aged, 80 and over (3533) 3533
antibody specificity (3532) 3532
cell biology (3481) 3481
therapy (3464) 3464
hematology (3424) 3424
mice, nude (3373) 3373
monoclonal-antibodies (3361) 3361
flow cytometry (3356) 3356
antineoplastic agents - therapeutic use (3347) 3347
cells (3339) 3339
neoplasms - therapy (3271) 3271
rats (3249) 3249
analysis (3203) 3203
medicine, research & experimental (3196) 3196
chemotherapy (3179) 3179
enzyme-linked immunosorbent assay (3172) 3172
antibody formation (3079) 3079
adolescent (3071) 3071
metastasis (3014) 3014
treatment outcome (3013) 3013
antibodies, monoclonal - pharmacology (3005) 3005
health aspects (2988) 2988
multidisciplinary sciences (2907) 2907
viral antibodies (2807) 2807
apoptosis (2780) 2780
immunoenzyme techniques (2775) 2775
biochemistry & molecular biology (2704) 2704
breast cancer (2609) 2609
neoplasms, experimental - immunology (2599) 2599
breast neoplasms - immunology (2567) 2567
antibodies, neoplasm - immunology (2528) 2528
medicine (2516) 2516
molecular sequence data (2505) 2505
article (2485) 2485
lymphocytes (2481) 2481
melanoma (2457) 2457
research article (2440) 2440
melanoma - immunology (2425) 2425
antibody (2406) 2406
mice, inbred c57bl (2384) 2384
diagnosis (2341) 2341
antibodies, monoclonal - administration & dosage (2273) 2273
child (2267) 2267
immunotherapy - methods (2265) 2265
blotting, western (2253) 2253
antibodies, monoclonal, humanized (2229) 2229
time factors (2203) 2203
gene expression (2199) 2199
lung neoplasms - immunology (2195) 2195
cells, cultured (2189) 2189
breast-cancer (2180) 2180
breast neoplasms - pathology (2153) 2153
antigens, neoplasm (2146) 2146
antigen (2091) 2091
in-vivo (2089) 2089
immunity, cellular (2082) 2082
antigen-antibody reactions (2081) 2081
amino acid sequence (2073) 2073
neoplasm staging (2047) 2047
neoplasms - drug therapy (2046) 2046
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (143) 143
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (4) 4
Chemistry (A D Allen) - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UTL at Downsview - May be requested (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (64746) 64746
Japanese (1078) 1078
Russian (801) 801
German (692) 692
Chinese (666) 666
French (508) 508
Spanish (187) 187
Polish (161) 161
Italian (155) 155
Czech (64) 64
Hungarian (31) 31
Dutch (20) 20
Swedish (18) 18
Bulgarian (17) 17
Danish (17) 17
Ukrainian (12) 12
Croatian (11) 11
Norwegian (10) 10
Romanian (9) 9
Serbian (9) 9
Slovak (9) 9
Turkish (8) 8
Hebrew (6) 6
Korean (6) 6
Portuguese (6) 6
Finnish (5) 5
Bosnian (1) 1
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 2, pp. 293 - 295
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2015, Volume 125, Issue 10, pp. 3981 - 3991
Adoptively transferred tumor-infiltrating T lymphocytes (TILs) that mediate complete regression of metastatic melanoma have been shown to recognize mutated... 
CD4+T CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | TCR | THERAPY | RECOGNITION | ANTI-CTLA-4 | MUTATIONAL LANDSCAPE | CD4(+) | ANTIGENS | BLOCKADE | Humans | Middle Aged | Neoplasm Proteins - immunology | Molecular Sequence Data | Male | Antigen-Antibody Reactions | Epitopes - immunology | Exome | Melanoma - genetics | Peptide Fragments - immunology | Adult | Female | Receptor, ErbB-2 - immunology | Neoplasm Proteins - genetics | Nuclear Proteins - genetics | Transcription Factors - immunology | Amino Acid Sequence | Antigens, Neoplasm - genetics | DNA-Binding Proteins - immunology | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Interferon-gamma Release Tests | Cells, Cultured | HLA-A1 Antigen - chemistry | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Epitopes - genetics | Nuclear Proteins - immunology | Melanoma - secondary | HLA-A2 Antigen - chemistry | Algorithms | Genes, erbB-2 | Melanoma - immunology | Adolescent | RNA, Neoplasm - genetics | T-Cell Antigen Receptor Specificity | T-Lymphocytes - immunology | HLA-A1 Antigen - immunology | DNA, Neoplasm - genetics | Mutation | Antigens, Neoplasm - classification | Lymphocytes, Tumor-Infiltrating - immunology | Physiological aspects | T cells | Lymphocytes | Identification and classification | Health aspects | Tumors | Antigens | Peptides | Cloning | Melanoma | T cell receptors | Metastasis | Cancer therapies | Patients | Studies | Immunotherapy | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 1, pp. 31 - 44
Polarization of tumor-associated macrophages (TAMs) to a proangiogenic/immune-suppressive (M2-like) phenotype and abnormal, hypoperfused vessels are hallmarks... 
Clodronic Acid - pharmacology | Gene Expression - genetics | Dendritic Cells - immunology | Humans | Pregnancy Proteins - genetics | Microvessels - pathology | Pregnancy Proteins - metabolism | Chemotactic Factors - metabolism | Neoplasm Metastasis - immunology | Antibodies - immunology | Neovascularization, Pathologic - immunology | Macrophages, Peritoneal - drug effects | Macrophages - pathology | Neoplasms - blood supply | Down-Regulation - genetics | Mice, Knockout | Macrophages - metabolism | Neoplasms - immunology | Cell Line, Tumor | Placenta Growth Factor | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Macrophages, Peritoneal - metabolism | Neoplasms - metabolism | CD8-Positive T-Lymphocytes - pathology | Gene Expression - drug effects | Regional Blood Flow - genetics | Dendritic Cells - pathology | Culture Media, Conditioned - pharmacology | Lung Neoplasms - pathology | Hypoxia - metabolism | Neovascularization, Pathologic - pathology | Regional Blood Flow - drug effects | Transfection | Lung Neoplasms - secondary | Neoplasms - genetics | Dendritic Cells - metabolism | Macrophages - immunology | Lung Neoplasms - genetics | Microvessels - ultrastructure | Cytokines - metabolism | Mice, Inbred C57BL | Microvessels - drug effects | Pregnancy Proteins - immunology | Antibodies - pharmacology | Proteins - genetics | Neoplasm Metastasis - genetics | Hypoxia - genetics | Lung Neoplasms - immunology | Animals | Proteins - metabolism | Endothelial Cells - cytology | Neoplasm Metastasis - pathology | Macrophages - drug effects | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Proteins - pharmacology | Neoplasms - pathology | Endothelial Cells - drug effects | Index Medicus
Journal Article
Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Bioindicators | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 42 - 51
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2014, Volume 111, Issue 32, pp. 11774 - 11779
Impressive responses have been observed in patients treated with checkpoint inhibitory anti-programmed cell death-1 (PD-1) or anticytotoxic... 
T lymphocytes | Tumor cell line | Myeloid cells | Medical treatment | Antibodies | Epigenetics | Cellular immunity | Mice | Tumors | Cancer | Exome | 5-azacytidine | Entinostat | Methyltransferase | HDAC | methyltransferase | MULTIDISCIPLINARY SCIENCES | TUMOR | ANTIBODY | DEPLETION | MECHANISMS | PI3K-ALPHA | entinostat | exome | IMMUNOTHERAPY | INFLAMMATION | DNA METHYLTRANSFERASE | HISTONE DEACETYLASE INHIBITORS | T-CELLS | Mammary Neoplasms, Experimental - immunology | Immunotherapy - methods | Humans | Histone Deacetylase Inhibitors - administration & dosage | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Benzamides - administration & dosage | Colorectal Neoplasms - therapy | Neoplasm Metastasis - immunology | Myeloid Cells - immunology | Female | Myeloid Cells - drug effects | Epigenesis, Genetic - drug effects | Mammary Neoplasms, Experimental - secondary | Azacitidine - administration & dosage | Neoplasm Metastasis - therapy | Pyridines - administration & dosage | Combined Modality Therapy | CTLA-4 Antigen - immunology | Mammary Neoplasms, Experimental - therapy | Neoplasm Metastasis - genetics | Animals | Colorectal Neoplasms - immunology | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Colorectal Neoplasms - secondary | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Rodents | Immunotherapy | Cytotoxicity | Metastasis | Polyclonal antibodies | Apoptosis | Index Medicus | Biological Sciences
Journal Article
Nature, ISSN 0028-0836, 07/2017, Volume 547, Issue 7662, pp. 217 - 221
Effective anti-tumour immunity in humans has been associated with the presence of T cells directed at cancer neoantigens(1), a class of HLA-bound peptides that... 
IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | CD4(+) T-CELLS | ANTIGENS | CANCER-IMMUNOTHERAPY | SEQUENCING DATA | EXPRESSION | PEPTIDE | PREDICTION | MOLECULES | EPITOPES | Amino Acid Sequence | Antigens, Neoplasm - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Antigens, Neoplasm - immunology | Humans | Cancer Vaccines - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Cancer Vaccines - chemistry | Antigens, Neoplasm - chemistry | Machine Learning | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Cancer Vaccines - immunology | Histocompatibility Antigens Class II - immunology | Melanoma - genetics | Melanoma - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Patient Safety | High-Throughput Nucleotide Sequencing | Mutation | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Precision Medicine - methods | Care and treatment | Methods | Melanoma | Cancer | Peptides | PD-1 protein | CD8 antigen | Vaccination | Feasibility analysis | Lymphocytes T | Vaccines | Tissues | Immunity | Thymus | Lymphocytes | Immunotherapy | Antigens | Feasibility studies | T cell receptors | Gene expression | Patients | Immunological tolerance | CD4 antigen | Studies | Immune checkpoint | Immunogenicity | Cell death | Histocompatibility antigen HLA | Tumors | Apoptosis | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 23, pp. 6050 - 6056
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2003, Volume 100, Issue 14, pp. 8372 - 8377
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a critical immunoregulatory molecule (expressed on activated T cells and a subset of regulatory T... 
T lymphocytes | Autoimmunity | Antigens | Biological Sciences | Lungs | Lymphocytes | Vaccination | Immunotherapy | Melanoma | Biopsies | Tumors | CTLA-4 BLOCKADE | IMMUNIZATION | IN-VITRO | ACTIVATION | DENDRITIC CELLS | MULTIDISCIPLINARY SCIENCES | COMBINATION IMMUNOTHERAPY | CD28 | PROLIFERATION | INTERLEUKIN-10 | CELL-CYCLE PROGRESSION | Peptides | Humans | Middle Aged | Neoplasm Proteins - immunology | Hepatitis, Autoimmune - etiology | Antibodies, Monoclonal - therapeutic use | Male | Antigens, Neoplasm - administration & dosage | gp100 Melanoma Antigen | Neoplasm Metastasis | Injections, Subcutaneous | Peptide Fragments - immunology | Autoimmune Diseases - pathology | Antibodies, Monoclonal - immunology | Antigens, Neoplasm - immunology | Lymphocyte Activation | Hepatitis, Autoimmune - immunology | Neoplasm Proteins - chemistry | Antigens, Differentiation - physiology | CTLA-4 Antigen | Dermatitis - etiology | Antigens, CD | Antigens, Differentiation - immunology | T-Lymphocyte Subsets - immunology | Antibodies, Neoplasm - therapeutic use | Injections, Intravenous | Dermatitis - immunology | Membrane Glycoproteins - chemistry | Antibodies, Monoclonal - adverse effects | Salvage Therapy | Colitis - pathology | Autoimmune Diseases - etiology | Hepatitis, Autoimmune - pathology | Immune Tolerance - immunology | Adult | Female | Membrane Glycoproteins - immunology | Colitis - immunology | T-Lymphocytes, Cytotoxic - immunology | Antibodies, Neoplasm - immunology | HLA-A2 Antigen - immunology | Peptide Fragments - administration & dosage | Vitiligo - immunology | Autoimmune Diseases - immunology | Vitiligo - etiology | Dermatitis - pathology | Colitis - etiology | Vitiligo - pathology | Melanoma - immunology | Melanoma - therapy | Antibodies, Neoplasm - adverse effects | Cancer regression | Physiological aspects | T cells | Patients | Research | Cancer | Index Medicus
Journal Article